# Infant Study of Inhaled Saline in Cystic Fibrosis

> **NCT00709280** · NA · COMPLETED · sponsor: **CF Therapeutics Development Network Coordinating Center** · enrollment: 321 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** 7% Hypertonic Saline (HS)
- **DRUG:** 0.9% Isotonic Saline (IS)

## Key facts

- **NCT ID:** NCT00709280
- **Lead sponsor:** CF Therapeutics Development Network Coordinating Center
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2013-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709280, "Infant Study of Inhaled Saline in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00709280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*